Healthcare Network

Healthcare Network

7 Posts · 0 Articles

Description
Our Vision · To be the most trusted partner in our clients' success endeavors · Our Commitment · To ensure our clients a ... See more
Group admin
What's going on?

travel_explore work person_search rate_review

group_work in Healthcare Network

Agricultural Biotechnology Market to Grow Significantly because of Rising Demand for Transgenic Seeds

2Mhg7.jpg

Receive a Free Sample Copy of this Report@

H8eIOpng
">
H8eIOpng

Agricultural Biotechnology Market Revenue Estimation, 2030

The global agricultural biotechnology market is expected to grow at a CAGR of 10.7% during 2021–2030. Increasing adoption of biofuels is the key trend observed

https://www.psmarketresearch.com/market-analysis/agricultural-biotechnology-market/report-sample?utm_source=bebee&utm_medium=Pramod

The world’s population has grown constantly since the age of human beings began; for example, in 1800 the population across the globe was under 1 billion, which has now, almost dramatically, risen to 7.7 billion. With this surging population, the need for enhancing the productivity of everything, for catering to the requirements of the people, has increased as well. This includes the productivity in agricultural fields, of course. In the old days, the only concern of people was to somehow grow enough food for their survival, and while survival is the major concern today as well, the priorities of the human race seem to have shifted.

Farming used to be the primary occupation in the past, but since the advent of industries and machines, the agricultural sector has somewhat been neglected. At the present time, however, there is a pressing need for increasing the agricultural productivity, which is why a number of technological advancements have occurred in the agricultural sector. One of such developments is the emergence of agricultural biotechnology, which involves the utilization of science for modifying animals and plants. This is done to breed out undesirable characteristics, such as low productivity and susceptibility to diseases. Furthermore, any beneficial traits can be bred in by making use of a gene which contains the specific characteristic.

thumb_up 0 relevants · comment 0 comments

group_work in Healthcare Network

Microbial Identification Market Expected to Boom in Asia-Pacific During 2016—2022

Receive a Free Sample Copy of this Report@

iZPYopng

Microbial Identification Market Size | Industry Report 2022

The microbial identification market size is witnessing a CAGR of 6.0% during 2016–2022. In the APAC region, the Japanese market is expected to generate the largest revenue by 2022, with a CAGR of 7.0% during the forecast period.

https://www.psmarketresearch.com/market-analysis/microbial-identification-market/report-sample?utm_source=bebee&utm_medium=Pramod

The global microbial identification market reached a valuation of $951.8 million in 2015 and is predicted to generate a revenue of $1,400.0 million by 2022. Furthermore, the market is predicted to demonstrate a CAGR of 6.0% between 2016 and 2022. The increasing healthcare expenditure, the rising prevalence of infectious diseases, the growing concerns being raised over food safety, and rapid technological advancements in microbial identification are the main factors fueling the progress of the market. 

Rising technological advancements and innovations in the domain of microbial identification is propelling the growth of the microbial identification market across the globe. The usage of technologically advanced and innovative techniques is making the microbial identification method more accurate and faster than the conventionally used assays. These techniques are highly cost-effective and provide a high throughput time. For example, the MALDI-TOF method is a very popular method, as it needs minimal consumables and provides quicker results.

iosTg.jpg

thumb_up 0 relevants · comment 0 comments

group_work in Healthcare Network

Protein A Market Growth to be Most Substantial in North America and Asia-Pacific (APAC)

Receive a Free Sample Copy of this Report@

ZX2jrpng
">
ZX2jrpng

Protein A Resin Market Size, Share, Trends and Forecast to 2030

Global protein A resin market size generated an estimated revenue of $486.4 million in 2019, which is projected to reach $1,020.7 million by 2030, Factors driving the growth of the market include surging burden of chronic diseases and growing geriatric population.

https://www.psmarketresearch.com/market-analysis/protein-a-resin-market/report-sample?utm_source=xing&utm_medium=Pramod

 

Cancer kills over 9.5 million people each year, as per the World Health Organization (WHO), which makes it the second leading cause of human mortality. With the increasing prevalence of this disease in developed as well as developing countries, the pressure on the medical fraternity to find an effective treatment is increasing. Though there are numerous therapies available, such as surgery, radiation, chemotherapy, and targeted medication, cancer has a high chance of coming back. This is why extensive research is being put in by pharmaceutical and biotechnology companies.

Two of the novel and most promising answers to cancer that such activities have yielded thus far are monoclonal antibodies (mAb) and proteins. To produce both these biopharmaceuticals, laboratories require something known as protein A resin. Thus, with the increasing focus on protein-based research, the protein A resin market, which valued $486.4 million in 2019, seems set on the path to reaching $1,020.7 million by 2030, at a 7.0% CAGR during 2019–2030. Originally found in the Staphylococcus aureus (S. aureus) bacteria, the protein is used to purify mAbs and commercially produce proteins via the method of immunoprecipitation.

wfcj7.jpg

thumb_up 0 relevants · comment 0 comments

group_work in Healthcare Network

Increase in Number of Diabetic Patients Driving Human Insulin Market

In 2017, the global human insulin (HI) market attained a value of $42.9 billion and is expected to advance at an 8.8% CAGR during the forecast period (2018–2023). The market is registering growth due to the surging geriatric population, rising exposure of people toward key risk factors resulting to diabetes, and increase in the number of diabetic patients. A type of synthetic insulin which mimics the insulin in humans is referred to as human insulin. Human insulin is generally created by growing insulin protein in bacteria, E. coli. 

bvQyt.jpg

In terms of product, the human insulin market is bifurcated into Hi delivery devices and HI drugs. Between these two, the HI drugs division dominated the market during the historical period (2013–2017), holding a share of 79.5% in 2017, and is further projected to retain its position during the forecast period. This is attributed to the rise in research & development activities for drug discovery and development, high prevalence of diabetes, and increasing demand for HI analogs. The HI delivery devices division is predicted to grow at the faster pace during the forecast period. 

Receive Sample Copy of this Report:

BTCUvpng
">
BTCUvpng

Human Insulin Market Size, Share | Industry Analysis Report, 2023

Human insulin market valued $42.9 billion in 2017 and is projected to register a CAGR of 8.8% during the period 2018-2023, on account of the rising number of diabetic patients

https://www.psmarketresearch.com/market-analysis/human-insulin-market/report-sample

thumb_up 1 relevant · comment 0 comments

group_work in Healthcare Network

Biopharmaceuticals: Saving Lives and Transforming Healthcare in Disease-Infested World

vde5B.jpg

The rising prevalence of neurological disorders is rapidly becoming a major health problem across the world. According to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016, neurological diseases were the main cause of disability-adjusted life years (DALYs) in people and the second-major cause of deaths in 2016. The study also found that the total number of DALYs and deaths caused due to neurological disorders grew by as much as 15% from 1990 to 2016.

This growing incidence of neurological disorders is massively pushing up the requirement for biopharmaceutical products. This is because these products have been found to be very useful for the management and treatment of several neurodegenerative disorders. Moreover, unlike the conventional medications, these drugs can be directly administered into the brain of a patient. Apart from neurological disorders, the rising prevalence of cancer and infectious diseases is also boosting the demand for biopharmaceuticals across the globe. 

Receive Sample Copy of this Report: 

ZwXYapng
">
ZwXYapng

Biopharmaceuticals Market Size | Industry Forecast Research Report

The U.S biopharmaceuticals market accounts for the maximum share in the North American market, mainly on account of the increasing prevalence of chronic diseases and rising per capita income of the country’s population.

https://www.psmarketresearch.com/market-analysis/biopharmaceuticals-market/report-sample

With the growing popularity of these drugs, medical researchers and scientists are conducting extensive research and development (R&D) activities in these products which will help them develop more technologically advanced biopharmaceuticals in the coming years. Furthermore, these rapid technological innovations and advancements are significantly increasing the survival rate of cancer and hepatitis patients all over the world. Many companies are making huge investments in the development and production of biopharmaceuticals. 

The main purpose behind these massive investments is to formulate medications and treatment procedures for many fatal diseases, especially the ones whose prevalence is rising at an alarming rate throughout the world. In addition to this, these investments are also being made for facilitating the mass production and commercialization of effective medications that have the ability to treat various life-threatening diseases and improve the survival rate of the patients suffering from them.

thumb_up 0 relevants · comment 0 comments

group_work in Healthcare Network

What are Factors Fuelling Progress of Hepatitis Drugs Market in North America?

Receive Sample Copy of this Report: 

WJiwtpng
">
WJiwtpng

Hepatitis Drugs Market Size, Competitive Share, Industry Trends Report

Among the countries of the region, the U.S. is a major contributor to the hepatitis drugs market and is estimated to progress at a CAGR of 30% during the forecast period,

https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market/report-sample

l94k1.jpg

The increasing prevalence of different types of hepatitis types, including hepatitis B and C, is one of the major factors propelling the demand for hepatitis drugs across the world. An article published by the Hepatitis B Foundation says that hepatitis is one of the leading causes of mortality in the world. According to the World Health Organization (WHO), almost 1 million deaths are caused every year by hepatitis B and the numerous complications associated with it in the world, and nearly 500,000 deaths are caused every year across the globe, because of hepatitis C.

The other major factor powering the surge in the demand for hepatitis drugs is the soaring number of government initiatives and incentives being enacted throughout the world for promoting the development of different types of drugs for hepatitis. In addition to this, many government organizations and firms such as the WHO, the U.S. Department of Health and Human Services (HHS), American Liver Foundation, and Centers for Disease Control and Prevention (CDC) are taking various measures for encouraging diagnosis, promoting the development of drug therapies, and helping the healthcare service providers to offer tailor-made solutions to patients. 

thumb_up 0 relevants · comment 0 comments

group_work in Healthcare Network

How is Increasing Geriatric Population Driving Muscle Relaxant Drugs Market?

Receive Sample Copy of this Report:

sL1K2png
">
sL1K2png

Muscle Relaxant Drugs Market Size, Share and Growth Analysis Report

Key factors driving the growth of the muscle relaxant drugs market includes increasing prevalence of skin diseases and harmful effects of ultraviolet radiation, rising disposable income leading to increasing spending on facial aesthetics therapy

https://www.psmarketresearch.com/market-analysis/muscle-relaxant-drugs-market/report-sample

FokAE.jpg

The incidence of skin diseases is rising all across the globe. In addition to this, the harmful effects of ultraviolet rays is compelling people to seek medical treatment for the damage is being caused to the skin. This along with the surging pollution, tobacco consumption, and excessive alcohol consumption reduce the elasticity of skin and makes it prone to sunburns. Furthermore, acne a major skin condition, is affecting millions of people all over the world. 

Other than these factors, the surging geriatric population is also creating high demand for muscle relaxant drugs all across the globe. As the name suggests, these drugs help in relieving muscle pain in neck, back, and other areas of the body. Since aged people are more susceptible to diseases, owing to their immunocompromised nature and physical weakness, they often require medical assistance for dealing with ailments. Muscle relaxants are often prescribed to old people, as these drugs can help in relieving their muscle pain. 

thumb_up 0 relevants · comment 0 comments

Do you want to manage your own group?

orange logo